Cambrex; Trade Idea
- Posted by ZorTrades
- on September 10th, 2012
CBM; Cambrex Corporation, a life sciences company, provides various products and services for the development and commercialization of new and generic therapeutics. It is primarily involved in the custom development and manufacture of pharmaceutical ingredients derived from organic chemistry. The company’s products include active pharmaceutical ingredients (APIs) and intermediates, generic and branded APIs, controlled substances, chiral compounds, high potency and technology-enhanced APIs, and fine chemicals
IBD Industry Rank; 21
- EPS percent change last quarter; +106%
- Last 3 quarters average EPS growth; +67%
- Sales +13%
- 6 quarters of increasing fund ownership

All you need ton know about CBM
The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.
blog comments powered by Disqus
-
Frank Zorrilla is the founder and chief investment officer of Zor Capital LLC.He began his Wall Street career 10 days after his 20th birthday when he became a Series 7 licensed stock broker. More »
-
-
Recent Posts
-
Archives
-